Therapeutic Strategy and Clinical Path of Facioscapulohumeral Muscular Dystrophy: Review of the Current Literature
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant genetic disease, which is caused by the mistaken expression of double homeobox protein 4 protein 4 (DUX4) in skeletal muscle. Patients with FSHD are usually accompanied by degenerative changes in the face, shoulders, and upper mu...
Saved in:
| Main Authors: | Qi Xie, Guangmei Ma, Yafeng Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-09-01
|
| Series: | Applied Sciences |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3417/14/18/8222 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Facioscapulohumeral muscular dystrophy: a review of pathogenesis, clinical symptoms, and treatment
by: T. Mikalauskas, et al.
Published: (2023-10-01) -
Genetics of Facioscapulohumeral Muscular Dystrophy
by: J Gordon Millichap
Published: (1991-11-01) -
Temporal variation in p38-mediated regulation of DUX4 in facioscapulohumeral muscular dystrophy
by: Rajanikanth Vangipurapu, et al.
Published: (2024-11-01) -
Speech and swallowing characteristics in patients with facioscapulohumeral muscular dystrophy
by: Vanessa Brzoskowski dos SANTOS, et al.
Published: (2022-02-01) -
Case report of a child with combined genetic pathology: cystic fibrosis and facioscapulohumeral progressive muscular dystrophy
by: O. A. Klochkova, et al.
Published: (2015-02-01)